Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Cumulative Effect, Period of Adoption, Adjustment [Member] Common Stock [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Additional Paid-in Capital [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] AOCI Attributable to Parent [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2021						7,745,404
Balance at Dec. 31, 2021						$ 774,541	$ 22,948,637	$ 2,521,730	$ (8,663,152)	$ 17,581,756
Common stock issued, $7 per share (in shares)						1,268
Common stock issued, $7 per share						$ 127	8,749	0	0	8,876
Costs associated with common stock issued						0	(1,705)	0	0	(1,705)
Other comprehensive income (loss)						0	0	(3,218,061)	0	(3,218,061)
Net income (loss)						$ 0	0	0	(1,147,431)	(1,147,431)
Balance (in shares) at Mar. 31, 2022						7,746,672
Balance at Mar. 31, 2022						$ 774,668	22,955,681	(696,331)	(9,810,583)	13,223,435
Balance (in shares) at Dec. 31, 2022						7,746,922
Balance at Dec. 31, 2022	$ 0	$ 0	$ 0	$ (150,373)	$ (150,373)	$ 774,693	22,955,458	(3,841,120)	(11,819,637)	8,069,394
Other comprehensive income (loss)						0	0	832,808	0	832,808
Net income (loss)						$ 0	0	0	275,451	275,451
Balance (in shares) at Mar. 31, 2023						7,746,922
Balance at Mar. 31, 2023						$ 774,693	$ 22,955,458	$ (3,008,312)	$ (11,694,559)	$ 9,027,280